1-7 of 7
keratitis
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clinical Manifestations and Prognostic Factors of Chronic Ocular Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation

Lan Y Wang, MD, Gloria B Chiu, OD, FAAO, FSLS, Rachel A Young, OD, Mojtaba Akhtari, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5731.
https://doi.org/10.1182/blood-2018-99-119903
Published: 2018
Journal Articles

Role of Systemic High-Dose Methotrexate and Combined Approaches in the Management of Vitreoretinal Diffuse Large B-Cell Lymphoma: A Single Center Experience 1990-2018

Alessia Castellino, MD, Jose Pulido, PhD, Patrick Johnston, Kay M. Ristow, BS, Nabila Nora Bennani, MD, David J Inwards, MD, William R. Macon, MD, Ivana N Micallef, MD, Rebecca L King, MD, Diva Salomao, MD, Thomas E. Witzig, MD, Thomas M. Habermann, MD, Grzegorz Nowakowski, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 574.
https://doi.org/10.1182/blood-2018-99-113826
Published: 2018
Journal Articles

Efficacy of Cidofovir in Treatment of BK Virus Induced Hemorrhagic Cystitis in Post Allogeneic Hematopoietic Cell Transplant Recipients

Eric Anthony Coomes, MD, Amanda Jacques, BScPharm, RPh, ACPR, Fotios V. Michelis, MD PhD, Dennis (Dong-Hwong) Kim, MD PhD, Santhosh Thyagu, MD, Auro Viswabandya, MDMDcine,DM Clinical Hematology, Jeff H. Lipton, MD PhD, Hans A. Messner, MD PhD, Uday Deotare, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5479.
https://doi.org/10.1182/blood.V130.Suppl_1.5479.5479
Published: 2017
Journal Articles

A Phase I Study of the Anti-CD79b THIOMAB TM -Drug Conjugate DCDS0780A in Patients (pts) with Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma (B-NHL)

Alex F. Herrera, MD, Manish R Patel, MD, John M. Burke, MD, Ranjana H. Advani, MD, Bruce D. Cheson, MD, Jeffrey P. Sharman, MD, Elicia Penuel, Andrew G. Polson, PhD, Ning Leng, PhD, Chunze Li, PhD, Eva Schuth, PhD, Anjali Vaze, PhD, Divya Samineni, PhD, Rebecca Elstrom, MDMA, Catherine S Diefenbach
Journal: Blood
Blood (2017) 130 (Supplement 1): 4129.
https://doi.org/10.1182/blood.V130.Suppl_1.4129.4129
Published: 2017
Journal Articles

First in Human Study with GSK2857916, an Antibody Drug Conjugated to Microtubule-Disrupting Agent Directed Against B-Cell Maturation Antigen (BCMA) in Patients with Relapsed/Refractory Multiple Myeloma (MM): Results from Study BMA117159 Part 1 Dose Escalation

Adam D. Cohen, MD, Rakesh Popat, Suzanne Trudel, MD, Paul G Richardson, MD, Ed N. Libby, III, MD, Nikoletta Lendvai, MDPhD, Larry D. Anderson, Jr., MD PhD, Heather J. Sutherland, MD PhD, Stephen DeWall, Catherine E Ellis, Zangdong He, Jolly Mazumdar, Catherine Wang, Joanna B. Opalinska, MD PhD, Peter M. Voorhees, MD
Journal: Blood
Blood (2016) 128 (22): 1148.
https://doi.org/10.1182/blood.V128.22.1148.1148
Published: 2016
Journal Articles

Chemotherapy Alone Is Effective to Treat Localized and Disseminated Ocular Adnexa Lymphomas

Wei-Li Ma, MD
Journal: Blood
Blood (2015) 126 (23): 2709.
https://doi.org/10.1182/blood.V126.23.2709.2709
Published: 2015
Journal Articles

Phase II Study Of Anti-CD19 Antibody Drug Conjugate (SAR3419) In Combination With Rituximab: Clinical Activity and Safety In Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (NCT01470456)

Bertrand Coiffier, MD, PhD, Catherine Thieblemont, MD, PhD, Sophie de Guibert, MD, Jehan Dupuis, MD, Vincent Ribrag, Réda Bouabdallah, MD, Franck Morschhauser, MD, PhD, Guillaume Cartron, MD, PhD, Steven Le Gouill, MD, PhD, Olivier Casasnovas, MD, Harald Holte, MD, PhD, Laurence Hatteville, Chiara Zilocchi, Corina Oprea, MD, Hervé Tilly, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 4395.
https://doi.org/10.1182/blood.V122.21.4395.4395
Published: 2013